LEADER 01311nam  2200361Ia 450 
001 9910698806003321
005 20090605145902.0
035   $a(CKB)5470000002397810
035   $a(OCoLC)371102360
035   $a(EXLCZ)995470000002397810
100   $a20090605d1999      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eefficacy studies to support marketing of fibrin sealant products manufactured for commercial use
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[1999]
215   $ai, 3 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on June 5, 2009).
300   $a"May 1999".
517   $aGuidance for industry 
606   $aFibrin
606   $aSealing compounds$xMarketing$xGovernment policy$zUnited States
615  0$aFibrin.
615  0$aSealing compounds$xMarketing$xGovernment policy
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698806003321
996   $aGuidance for industry$93434577
997   $aUNINA